Explore the Global Peptide Therapeutics Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Peptide Therapeutics Market

Key Insight

Peptide therapeutics sales will expand through 2036, with cancer holding 25.3% of the application segment in 2026, driven by steady procurement volumes and standardization across manufacturing applications. The market was valued at USD 46.60 billion in 2025 and is expected to be worth USD 143.99 billion by 2036.

May 13, 2026

Anurag Sharma

425 Pages

Cite this Report

Peptide Therapeutics Market

https://www.futuremarketinsights.com/reports/peptide-therapeutics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

AstraZeneca plc
Eli Lilly and Company
Ipsen S.A
Novo Nordisk A/S
Berkshire Hathaway

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Peptide Therapeutics Market

Key Players

Similar Industry Reports